Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide for prevention and treatment of radiation-induced oral mucositis in nasopharyngeal carcinoma
ChiCTR1800015163Phase 4Not yet recruiting
- Sponsor
- Jianyang People's Hospital
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of thalidomide in stomatitis (2 arms), sponsored by Jianyang People's Hospital. Primary endpoints: Visual analogue scale and RTOG mucosal radiation injury grade. Planned start Apr 2018; status: not yet recruiting.
02
Drugs
thalidomide
03
Conditions
stomatitis
Beyond the preview
Go deeper on ChiCTR1800015163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015163.